Approval · Notice of Compliance 27730 · 2022
FLUCELVAX QUAD: Notice of Compliance 27730
Issued March 8, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 27730
- Date
- March 8, 2022
- Company
- Seqirus Uk LimitedMaidenhead, Berkshire, United Kingdom
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Expansion of indication to include : age 6 months of age or older to the approved indication
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| FLUCELVAX QUAD | Not yet assigned | — |
Medicinal ingredients
- HAEMAGGLUTININ-STRAIN A(H1N1) 15 MCG per 0.5ML
- HAEMAGGLUTININ-STRAIN A(H3N2) 15 MCG per 0.5ML
- HAEMAGGLUTININ-STRAIN B(VICTORIA) 15 MCG per 0.5ML
- HAEMAGGLUTININ-STRAIN B(YAMAGATA) 15 MCG per 0.5ML